RxDoctor Payments Data

Jack Zackey, DO

Obstetrics & Gynecology · Florence, ALNPI 1750887386

Payments from drug & device makers

$2,712in general payments, 2019–2025

Across 65 payments — averaging $41.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$1K
  • Astellas Pharma US Inc$400
  • Amgen$116
  • Boston Scientific$102
  • Medtronic$83
  • Novo Nordisk$77
  • plus $481 from 15 others

What the payments were for

  • Speaking & faculty fees$251%
  • Travel & lodging$1,30248%
  • Food & beverage$1,12141%
  • Education$26410%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,712 in reported general payments places this provider in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.

See all obstetrics & gynecology providers in Alabama

Medicare billing

Part B allowed, 2024
$53,369
Medicare patients
187
Services billed
768

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol163$11,105
GemtesaVibegron13$6,295
DottiEstradiol18$1,834
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet22$1,346
Risedronate Sodium13$1,005
Alendronate Sodium55$596
Oxybutynin Chloride ErOxybutynin Chloride21$580
Clobetasol Propionate11$475
ValacyclovirValacyclovir Hcl14$346
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$209
Oxybutynin Chloride12$192
Metronidazole14$160
Fluconazole20$99
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$75
Ibuprofen19$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$41$6,29513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.

Other obstetrics & gynecology in Florence

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →